This report provides a comprehensive and structured analysis of 639 metabolic collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Metabolic Collaboration and Licensing Deals 2019-2026" report has been added to ResearchAndMarkets.com's offering.

The definitive benchmark for metabolic dealmaking

Metabolic partnering spans a range of large, chronic disease indications, with deal structures reflecting long-term treatment paradigms, significant commercial potential, and evolving innovation across the space.

This report provides a comprehensive and structured analysis of 639 metabolic collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how metabolic deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a high-value and commercially driven therapeutic landscape
Full visibility into deal structure and execution

Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections

This level of transparency is critical to understanding how value, risk, and control are allocated within metabolic partnerships, particularly in areas driven by large patient populations and long-term treatment dynamics.

Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data

What's included?

639 metabolic collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for metabolic dealmaking

Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how metabolic partnerships are structured, negotiated, and valued.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in metabolic dealmaking
2.1. Introduction
2.2. Metabolic partnering over the years
2.3. Metabolic partnering by deal type
2.4. Metabolic partnering by industry sector
2.5. Metabolic partnering by stage of development
2.6. Metabolic partnering by technology type
2.7. Metabolic partnering by therapeutic indication

Chapter 3 - Financial deal terms for metabolic partnering
3.1. Introduction
3.2. Disclosed financials terms for metabolic partnering
3.3. Metabolic partnering headline values
3.4. Metabolic deal upfront payments
3.5. Metabolic deal milestone payments
3.6. Metabolic royalty rates

Chapter 4 - Leading metabolic deals and dealmakers
4.1. Introduction
4.2. Most active in metabolic partnering
4.3. List of most active dealmakers in metabolic
4.4. Top metabolic deals by value

Chapter 5 - Metabolic contract document directory
5.1. Introduction
5.2. Metabolic partnering deals where contract document available

Chapter 6 - Metabolic dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by metabolic therapeutic target

Deal directory

Deal directory - Metabolic deals by company A-Z
Deal directory - Metabolic deals by technology type
Deal type definitions

Companies Featured

3DR Labs
4P-Pharma
23andMe
180 Life Sciences
Abbisko Therapeutics
Abbott Laboratories
AbCellera Biologics
Abeona Therapeutics
AcelaBio
Acentrus Specialty
Acenzia
Aceragen
AgeX Therapeutics
AiCuris
Ajinomoto
Akcea Therapeutics
Akero Therapeutics
Albert Einstein College of Medicine
Albireo
Alexion Pharmaceuticals
Alfasigma
Aligos Therapeutics
Alimentiv
AliveCor
Alkem Laboratories
Allele Biotechnology and Pharmaceuticals
AllerGenis
Allevi 3D
AM Chemicals
A Menarini Diagnostics
American Association for the Study of Liver Diseases
American Diabetes Association
Amgen
Amicus Therapeutics
AmideBio
AMMTeK
Amneal Pharmaceuticals
Amolyt Pharma
AMRA Medical
Amyris
Anagram Therapeutics
Angers University
Anji Pharma
Antares Pharma
Apellis Pharmaceuticals
Apollon Formularies
Argon Medical Devices
Arjuna Naturals
Arrowhead Pharmaceuticals
Arzeda
Ascendis Pharma
Ascensia Diabetes Care
Ascletis
Asklepios Biopharmaceutical
Aspect Biosystems
Astellas Pharma
Astex Pharmaceuticals
AstraZeneca
ATUM
Avicanna
Avrobio
Axcella
AXIM Biotechnologies
Better Therapeutics
Beyond Type 1
Bigfoot Biomedical
Bill and Melinda Gates Foundation
Bioadaptives
biOasis Technologies
Biocon
BIOCORP
Biodexa Pharmaceuticals
BioHarvest Sciences
BIOHM Health Inc
BioLinQ
Biolojic Design
BioMed X Innovation Center
BioPep
Biosidus
Biosplice
Bird Foundation
Boehringer Ingelheim
Bond Pet Foods
Bonne Sante Group
Boston Scientific
BPGbio
Brand Institute
Bridge Biotherapeutics
Brigham and Women's Hospital
BrightInsight
Brightseed
Camurus
Can-Fite BioPharma
CANbridge Pharmaceuticals
Cantex Pharmaceuticals
Capillary Biomedical
Cardiff University
Cardinal Health
Cardiovascular Solutions of Central Mississippi
CASI Pharmaceuticals
Catalent
Cellarity
CELLINK
Celloram
Centene
Center for Genomic Regulation
Centogene
Centre for Commercialization of Regenerative Medicine (CCRM)
Centrus Health Clinics
Century Therapeutics
Chemify
Chiasma
Chiesi Farmaceutici
Children's Hospital at Montefiore
Children's Hospital Boston
Chongqing Yao Pharmaceutical
ChromaDex
Cibus Global
Citrine Medicine
City of Hope
Civica Rx
CJ CheilJedang
Clarus Therapeutics
Clinigen
CN Bio
Code Biotherapeutics
Codexis
Columbia University
Crinetics
CRISPR Therapeutics
Critical Path Institute (C-Path)
Crossject
CSPC Pharmaceutical Group
Cukierman & Co Life Sciences
Cure Genetics
Cycle Pharmaceuticals
Cyclo Therapeutics
CymaBay Therapeutics
Cystic Fibrosis Foundation
Cytoo
Dawn Health
Deargen
Decode Health
Deep Apple Therapeutics
Deerfield Management
Defense Health Agency (US)
DEKA Research and Development
Delta 4
Delve Health
Department of Veterans Affairs
DigiLab
Diomics
Diurnal
DKSH
DNAnexus
DolCas Biotech
Dong-A ST
DoveTree Medicines
DreaMed Diabetes
DSM
Duke Clinical Research Institute (DCRI)
Duke University
DuPont Pharmaceuticals
Dyadic International
Dyno Therapeutics
EatLove
Eccogene
Echosens
EffRx Pharmaceuticals
eGenesis
Ei.Ventures
EirGen Pharma
Elcelyx Therapeutics
Eledon Pharmaceuticals
Entera Bio
Enzolytics
Enzyvant Science
Epitomee Medical
Er-Kim
Eracal Therapeutics
Eton Pharmaceuticals
European Union Regional Development Fund
European Wellness Biomedical Group
EVA Pharma
EverlyWell
Eversana
EVerZom
Evgen Pharma
Evidation Health
Evo Foods
EVOQ Therapeutics
Evotec
Evozyne
Ewopharma
ExCEEd Orphan
Fermbox Bio
First Wave Bio
FitBit
Flagship Biosciences
G3 Therapeutics
G42 Healthcare
Gain Therapeutics
Galapagos
Galectin Therapeutics
Galmed Pharmaceuticals
Gan & Lee
Gannex Pharma
Gastrologix
GATC Health
GC Pharma
GE Healthcare
GEMMA Biotherapeutics
Genentech
General Automation Lab Technologies
Generation Bio
Generex Biotechnology
Genethon
Genevant Sciences
Goldfinch Bio
GoodRx
Graviton Bioscience
Group K Diagnostics
GSK
Halberd
Hamilton Company
Hanmi Pharmaceutical
Hansa Biopharma
Harvard Medical School
Haselmeier
Hatch Medical
HAYA Therapeutics
Health2Sync
Healthimation
Health Network Laboratories
Healthy.io
Healthy Grain
HemoShear
Hepalys Pharma
HepaTx
Hepion Pharmaceuticals
iECURE
Imagine Pharmaceuticals
Imaware
Immedica
Immusoft
Immuthera
Imperial College London
Indiana University
Ingredion
Innovate UK
Innovation Zed
Innovent Biologics
Inserm
Insilico Medicine
Insitro
InSphero
Institute of Endocrinology
Metabolism
and Reproduction
Institut National Recherche Agronomique
Insulet
Intact Therapeutics
Integral Molecular
InterAx Biotech
Intercept Pharmaceuticals
International Diabetes Federation (IDF)
International Niemann-Pick Disease Registry
Inventiva
Invitae
JCR Pharmaceuticals
Jennewein Biotechnologie
Jiangsu Chia Tai Tianqing Pharmaceutical
Jiangsu Hansoh Pharmaceutical
Jinggangshan University
Johns Hopkins Medicine (JHM)
Johns Hopkins University
Journey Medical
Jugular
Jumpcan Pharmaceutical
Juntendo University
Juvena Therapeutics
Juvenescence
Juvenile Diabetes Research Foundation
Kadimastem
Kahn-Sagol-Maccabi
Kaken Pharmaceutical
Kaleido Biosciences
Kalsec
Katana Pharmaceuticals
KeyBioScience
Klue
Know Labs
Kore
Korro Bio
Kyowa Hakko Kirin
Labcyte
LogicBio Therapeutics
Lonza
LUCA Science
Lumen Biomedical
Luminex
Lumos Pharma
Lurie Children's Hospital of Chicago
LyGenesis
Lygos
LY Research
Lysando
Lysogene
mAbXience
Madrigal Pharmaceuticals
Mammoth Biosciences
Mandos
MannKind Biopharmaceuticals
Martin Pharmaceuticals
Massachusetts General Hospital
Massachusetts Institute of Technology
Mass General Brigham
Max Biopharma
MedImmune
Medipal Holdings
Medisca
Medison Pharma
Medtronic
Meitheal Pharmaceuticals
Melior Pharmaceuticals
Merck and Co
Merck KGaA
Merieux NutriSciences
Merz
Mesh Bio
Metaba
Meta Healthcare
MetaSight Diagnostics
Metro Health
Metsera
MiNA Therapeutics
Minerva Foods
Minovia Therapeutics
Miromatrix Medical
Mirum Pharmaceuticals
Mission Bio
Mitobridge
Mitsubishi Tanabe Pharma
MyBiotics Pharma
MySugarWatch DuoPack
Namocell
NAMUH
Nano-X Imaging
NanoVation Therapeutics
NASH Network
National Cerebral and Cardiovascular Disease Research Center
National Heart
Lung and Blood Institute
National Institute of Arthritis and Musculoskeletal Diseases
National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
National Organization for Rare Disorders
National Research Council Canada
NeuroBiogen
NeuroBo Pharmaceuticals
Neurocrine Biosciences
Neurodon
NeuroFront
Newsoara Biopharma
New Wave Ventures
Neximmune
NGM Biopharmaceuticals
Nicoya
Nimbus Therapeutics
NIMIUM Therapeutics
NLC Pharma
Norgine
Northwestern University
NorthX Biologics
Novaremed
Novartis
Novasep
Novitium Pharma
Novo Integrated Sciences
Novo Nordisk
Nuformix
Numares
OmniaBio
One World Products
Ono Pharmaceutical
Onward Therapeutics
Open Book Extracts
OPKO Biologics
OPKO Health
Optithera
Optomed
Oramed Pharmaceuticals
Orchard Therapeutics
Oregon Health Sciences University
OrganOx
Orgenesis
OrphanPacific
OrsoBio
OSE Immunotherapeutics
OSI Pharmaceuticals
Penn State Microbiome Center
PeptiDream
Performance Inspired Nutrition
PerkinElmer
Perspectum Diagnostics
Pfizer
PharmaCyte Biotech
Pharmanest
Pharmanovia
Pharmathen
Pharmavite
Phenex
Phillips-Medisize
PhoreMost
Photys Therapeutics
Phytolon
Piramal
Pliant Therapeutics
Pluristem Therapeutics
Pluristyx
Polyganics
Population Health Partners
PRA Health Sciences
Precision Diabetes
Premier Inc
Provention Bio
Psyence Therapeutics
Pulmatrix
Purnovate
Qilu Pharmaceutical
Quell Therapeutics
Quest Diagnostics
Radius Health
Rallybio
Rare Disease Company Coalition
Raziel Therapeutics
RC2
Readout Health
Reata Pharmaceuticals
Recordati
Redox
Redwire
Regeneron Pharmaceuticals
Regenxbio
Regional Cancer Institute of Montpellier
Regor Therapeutics
Relation Therapeutics
Relief Therapeutics
Roche Diagnostics
RTW Investments
SafeTraces
Sagimet Biosciences
Salipro Biotech
Salix Pharmaceuticals
Sanacor
Sandhill One
SanegeneBio
Sanofi
Sanofi US Services
Sanwa Kagaku Kenkyusho
Science 37
Scientific Research Council
Scilex Holding
Scivita Medical Technology
Sciwind Biosciences
SCM Pharma
Seal Rock Therapeutics
Second Genome
Selecta Biosciences
Shionogi Pharma
Sichuan Deebio Pharmaceutical
Siemens Healthineers
Sigilon Therapeutics
Silence Therapeutics
Singapore General Hospital
Sino Biopharmaceutical
Sinopia Biosciences
Sirion Biotech
Sirona Biochem
SocialDiabetes
Societal CDMO
Solarea Bio
SomaLogic
Sonnet BioTherapeutics
Stevanato
Structure Therapeutics
Sumitomo Dainippon Pharma
Summit Clinical Research
Sun Genomics
Sunshine Lake Pharma
Surrozen
Suzhou Ribo Life Science
Suzhou Ribo Life Sciences
Synbiotech
Synbiotic Health
SynerK
Syneron Bio
Synlogic
Synspira
Synthetic Biologics
T-Cell Protect Hellas
Taisho Pharmaceutical
TaiwanJ Pharmaceuticals
Takara Bio
Takeda Pharmaceutical
Tandem Diabetes Care
Target RWE
Tate & Lyle
Taysha Gene Therapies
Tetris Pharma
Texas A&M University
The Healthy Aging Company
Theracell
TheracosBio
The United Laboratories
Thorne HealthTech
Tianjin JuveStar Biotech
Tiburio Therapeutics
Tidepool
Tnuva Group
Todos Medical
Tome Biosciences
Tonghua Dongbao Pharma
TONIX Pharmaceuticals
Torrent Pharmaceuticals
Tottori University
TPMENA
TransThera
TransThera Sciences
TreeFrog Therapeutics
Trovita Health Science
True Diagnostics
University of Alberta
University of British Columbia
University of California
San Diego
University of California
San Diego (UCSD) School of Medicine
University of California Irvine
University of California Los Angeles
University of California San Francisco
University of Chicago
University of Colorado
University of Edinburgh
University of Pennsylvania
University of Pittsburgh
University of Sheffield
University of Technology Sydney
University of Texas
University of Toronto
University of Virginia
University of Washington
University of West Indies
University of Wisconsin-Madison
University Paris Diderot
Vanderbilt University
Variant Bio
VELL Health
Ventus Therapeutics
Verantos
Veravas
Verdiva Bio
Versiti Blood Research Institute
Virginia Commonwealth University
Virginia Tech
Virtual Health Partners
VisionQuest Biomedical
Visirna Therapeutics
VistaGen Therapeutics
Vitro Biopharma
Vivani Medical
Vivet Therapeutics
Vivici
Vivtex
VOTIS Subdermal Imaging Technologies
vTv Therapeutics
Willow Biosciences
Winhealth Pharma Group
W L Gore
Worldwide Clinical Trials
Wuhan General Group
XERIS Pharmaceuticals
Xlife Sciences
Xoma
XtalPi
Yale University
Zag Bio
Zealand Pharma
Zelira Therapeutics
Zhejiang Hisun Pharmaceutical
Zifo
ZyVersa Therapeutics

For more information about this report visit https://www.researchandmarkets.com/r/4rzhkh

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900

Metabolic Collaboration and Licensing Agreements Benchmark Report 2026: Access Structured Analysis of 639 - Financial Terms, Upfronts, Stage, Asset Type, Milestones, and Royalties